Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

P&G Health Care Unit Boosted By Oral Care, Prilosec Faces Competition

This article was originally published in The Tan Sheet

Executive Summary

Procter & Gamble's oral care and feminine care businesses led growth of its health care division during the firm's fiscal 2008 third quarter, P&G reported during an April 30 analyst call

You may also be interested in...



P&G Creates Prilosec OTC Social Network To "Sponsor Everything You Do"

Analysts say the firm is on target appealing to consumers' emotions, and interactive online marketing is beginning to reach across the gamut of consumers.

P&G Creates Prilosec OTC Social Network To "Sponsor Everything You Do"

Analysts say the firm is on target appealing to consumers' emotions, and interactive online marketing is beginning to reach across the gamut of consumers.

P&G Creates Prilosec OTC Social Network To "Sponsor Everything You Do"

Procter & Gamble aims to gain market share for its proton pump inhibitor Prilosec OTC by harnessing the power of interactive digital media and social networking to build consumers' emotional connections to the product

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS101622

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel